ALS, Secondary Progressive MS & Alzheimer’s Disease: Commonly Rooted in Mitochondrial Dysfunction in a 14-Day MP-101 Clinical CSF Biomarker Basket Study
Time: 11:10 am
day: CONFERENCE DAY ONE
Details:
- MP-101: Lowers damage while promoting repair
- MP-101: Mitochondrial-specific, biophysics MOA, non-genomic pharmacology cascading into cellular remodeling
- MP-101: Oral brain penetrating once-per-day treatment waking up compensatory mechanism Pro-Survival
